Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Frieden TR"" wg kryterium: Autor


Tytuł :
Factores de riesgo para la infección por tuberculosis resistente: Metanálisis de estudios de casos y controles
Autorzy :
Higuita Gutiérrez, Luis Felipe
Arango Franco, Carlos Andrés
Cardona Arias, Jaiberth Antonio
World Health Organization. Global tuberulosis report [Internet]. 2016 [cited March 4
2017]. Available from: http://www.who.int/tb/publications/global_report/en/. ; World Health Organization. Estrategia Fin a la TB: objetivos e indicadores. [Internet]. 2016 [cited marzo 2017]. Available from: http://www.who.int/tb/strategy/ end-tb/es/ ; World Health Organization. Drug-resistant TB Surveillance and Response [Internet]. 2014 [cited marzo 2017]. Available from: http://www.who.int/tb/publications/global_report/gtbr14_supplement_web_v3.pdf ; Frieden TR
Sterling T
Pablos-Mendez A
et al. The emergence of drug-resistant tuberculosis in New York City. The New England journal of medicine. 1993;328(8):521-6. ; Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide
2000- 2004. MMWR Morbidity and mortality weekly report. 2006;55(11):301-5. ; Velayati AA
Masjedi MR
Farnia P
et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Chest. 2009;136(2):420-5. ; Udwadia ZF
Amale RA
Ajbani KK
et al. Totally drug-resistant tuberculosis in India. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(4):579-81. ; Fox GJ
Barry SE
Britton WJ
et al. Contact investigation for tuberculosis: a systematic review and meta-analysis. The European respiratory journal. 2013;41(1):140-56. ; Suchindran S
Brouwer ES
Van Rie A. Is HIV Infection a Risk Factor for Multi-Drug Resistant Tuberculosis? A Systematic Review. PloS one. 2009;4(5):e5561. ; Biadglegne F
Rodloff AC
Sack U. Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiology and infection. 2015;143(5):887-900. ; Rifat M
Milton AH
Hall J
et al. Development of multidrug resistant tuberculosis in Bangladesh: a case-control study on risk factors. PloS one. 2014;9(8):e105214. ; Brewer TF
Choi HW
Seas C
et al. Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatment. PloS one. 2011;6(10):e25861. ; Cardona Arias J
Higuita-Gutierrez
LF
Rios Osorio LA Revisiones sistemáticas de la literatura científica. Colombia. Universidad Cooperativa de Colombia
2016. ; Faustini A
Hall AJ
Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61(2):158-63. ; Zhao P
Li XJ
Zhang SF
et al. Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis. The Journal of international medical research. 2012;40(2):436-45. ; Berhan A
Berhan Y
Yizengaw D. A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection? Ethiopian journal of health sciences. 2013;23(3):271-82. ; Álvarez-Martínez H
Pérez-Campos E. Causalidad en medicina. Gaceta médica de México. 2004;140:467-72. ; Bradford Hill A. Ambiente y enfermedad: ¿Asociación o causación? Revista Cubana de Salud Pública. 2008;34(2). ; Casal M
Vaquero M
Rinder H
et al. A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microbial drug resistance. 2005;11(1):62-7. ; Ahmad AM
Akhtar S
Hasan R
et al. Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case-control study. International journal of mycobacteriology. 2012;1(3):137-42. ; Mulu W
Mekonnen D
Yimer M
et al. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. African Health Sciences. 2015;15(2):368-77. ; Ignatyeva O
Balabanova Y
Nikolayevskyy V
et al. Resistance profile and risk factors of drug resistant tuberculosis in the Baltic countries. Tuberculosis. 2015;95(5):581-8. ; Fischl MA
Uttamchandani RB
Daikos GL
et al. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with hiv infection. Annals of Internal Medicine. 1992;117(3):177-83. ; Balaji V
Daley P
Anand AA
et al. Risk factors for MDR and XDR-TB in a tertiary referral hospital in India. PloS one. 2010;5(3):e9527. ; Souza MBd
Antunes CMdF
Garcia GF. Perfil de sensibilidade e fatores de risco associados à resistência do Mycobacterium tuberculosis
em centro de referência de doenças infecto-contagiosas de Minas Gerais. Jornal Brasileiro de Pneumologia. 2006;32:430-7. ; El Mahalli AA
Al-Qahtani MF. Predictors of drug resistance in tuberculosis patients in the Eastern Province
Saudi Arabia. The Journal of the Egyptian Public Health Association. 2015;90(1):24-8. ; Flora MS
Amin MN
Karim MR
et al. Risk factors of multi-drug-resistant tuberculosis in Bangladeshi population: a case control study. Bangladesh Medical Research Council bulletin. 2013;39(1):34-41. ; Li XX
Lu W
Zu RQ
et al. Comparing risk factors for primary multidrug-resistant tuberculosis and primary drug-susceptible tuberculosis in Jiangsu province
China: a matched-pairs case-control study. The American journal of tropical medicine and hygiene. 2015;92(2):280-5. ; Mohd Shariff N
Shah SA
Kamaludin F. Previous treatment
sputum-smear nonconversion
and suburban living: The risk factors of multidrug-resistant tuberculosis among Malaysians. International journal of mycobacteriology. 2016;5(1):51-8. ; Li W-B
Zhang Y-Q
Xing J
et al. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province
China. Infectious Diseases of Poverty. 2015;4:14. doi:10.1186/s40249-015-0045-1. ; Maguire H
Brailsford S
Carless J
et al. Large outbreak of isoniazid-monoresistant tuberculosis in London
1995 to 2006: case-control study and recommendations. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2011;16(13). ; Law WS
Yew WW
Chiu Leung C
et al. Risk factors for multidrug-resistant tuberculosis in Hong Kong. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2008;12(9):1065-70. ; Diande S
Sangare L
Kouanda S
et al. Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso
West Africa. Microbial drug resistance. 2009;15(3):217-21. ; Ávalos Rodríguez AC
Imán Izquierdo FJC
Virú Loza MA
et al. Factores asociados a tuberculosis multidrogorresistente primaria en pacientes de Callao
Perú. Anales de la Facultad de Medicina. 2014; 75(3):233-236 ; Andrews JR
Shah NS
Weissman D
et al. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PloS one. 2010;5(12):e15735. ; Elmi OS
Hasan H
Abdullah S
et al. Multidrugresistant tuberculosis and risk factors associated with its development: a retrospective study. Journal of infection in developing countries. 2015;9(10):1076-85. ; Gomez-Gomez A
Magana-Aquino M
Lopez-Meza S
et al. Diabetes and Other Risk Factors for Multi-drug Resistant Tuberculosis in a Mexican Population with Pulmonary Tuberculosis: Case Control Study. Archives of medical research. 2015;46(2):142-8. ; Barroso EC
Mota RMS
Oliveira ACM
et al. Papel da tuberculose domiciliar no surgimento da tuberculose multirresistente. Jornal Brasileiro de Pneumologia. 2004;30:46-52 ; Zhang C
Wang Y
Shi G
et al. Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study. BMC Public Health. 2015;16:42. ; Ricks PM
Mavhunga F
Modi S
et al. Characteristics of multidrug-resistant tuberculosis in Namibia. BMC infectious diseases. 2012;12:385. ; Pearson ML
Jereb JA
Frieden TR
et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med. 1992;117(3):191-6. ; Hirpa S
Medhin G
Girma B
et al. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 2013;13:782. ; Pritchard AJ
Hayward AC
Monk PN
et al. Risk factors for drug resistant tuberculosis in Leicestershire--poor adherence to treatment remains an important cause of resistance. Epidemiology and infection. 2003;130(3):481-3. ; Chen S
Huai P
Wang X
et al. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2013;17(12):e1116-20. ; Clark CM
Li J
Driver CR
et al. Risk factors for drug-resistant tuberculosis among non-US-born persons in New York City. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2005;9(9):964-9. ; Nodieva A
Jansone I
Broka L
et al. Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2010;14(4):427-33. ; Smith T
Wolff KA
Nguyen L. Molecular biology of drug resistance in Mycobacterium tuberculosis. Current topics in microbiology and immunology. 2013;374:53-80. ; Karumbi J
Garner P. Directly observed therapy for treating tuberculosis. The Cochrane Database of Systematic Reviews. (5):1-56. ; Cohen T
Sommers B
Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. The Lancet Infectious diseases. 2003;3(1):13-21. ; Merker M
Blin C
Mona S
et al. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nature genetics. 2015;47(3):242-9. ; Vaquero M
Gutierrez J
Pokaż więcej
Temat :
Mycobacterium tuberculosis
Antibióticos antituberculosos
Farmacorresistencia microbian
Estudios de Casos y Controles
Metanálisis
Antibiotics antitubercular
Drug resistance
Microbial
Case-Control Studies
Meta-Analysis
Źródło :
World Health Organization. Global tuberulosis report [Internet]. 2016 [cited March 4, 2017]. Available from: http://www.who.int/tb/publications/global_report/en/. ; World Health Organization. Estrategia Fin a la TB: objetivos e indicadores. [Internet]. 2016 [cited marzo 2017]. Available from: http://www.who.int/tb/strategy/ end-tb/es/ ; World Health Organization. Drug-resistant TB Surveillance and Response [Internet]. 2014 [cited marzo 2017]. Available from: http://www.who.int/tb/publications/global_report/gtbr14_supplement_web_v3.pdf ; Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. The New England journal of medicine. 1993;328(8):521-6. ; Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000- 2004. MMWR Morbidity ....
Opis pliku :
2-13
Relacje :
Revista Española de Salud Pública; http://scielo.isciii.es/pdf/resp/v92/1135-5727-resp-92-e201809067.pdf; http://hdl.handle.net/20.500.12494/16147; Higuita-Gutiérrez LF, Arango-Franco CA, Cardona-Arias JA. Factores de riesgo para la infección por tuberculosis resistente: Metanálisis de estudios de casos y controles. Rev Esp Salud Pública.2018;92:7 de septiembre e201809067
Dostępność :
https://doi.org/10.1186/s40249-015-0045-1
http://hdl.handle.net/20.500.12494/16147
Czasopismo naukowe
Tytuł :
Genómica y transcriptómica comparativa en cepas de Leishmania de Colombia ; Genomic and transcriptomic comparative in Leishmania species from Colombia
Autorzy :
Patiño, Luz H.
instname:Universidad del Rosario ; reponame:Repositorio Institucional EdocUR ; Herwaldt BL: Leishmaniasis. Lancet 1999
354(9185):1191-1199. ; Fraga J
Veland N
Montalvo AM
Praet N
Boggild AK
Valencia BM
Arevalo J
Llanos-Cuentas A
Dujardin JC
Van der Auwera G: Accurate and rapid species typing from cutaneous and mucocutaneous leishmaniasis lesions of the New World. Diagnostic microbiology and infectious disease 2012
74(2):142- 150. ; Marquis N
Gourbal B
Rosen BP
Mukhopadhyay R
Ouellette M: Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Molecular microbiology 2005
57(6):1690-1699. ; Desjeux P: Leishmaniasis: current situation and new perspectives. Comparative immunology
microbiology and infectious diseases 2004
27(5):305- 318. ; Hashiguchi Y
Gomez EL
Kato H
Martini LR
Velez LN
Uezato H: Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review. Tropical medicine and health 2016
44:2. ; Reithinger R
Louzir H
Pirmez C
Alexander B
Brooker S: Cutaneous leishmaniasis. The Lancet Infectious diseases 2007
7(9):581-596. ; van Griensven J
Diro E: Visceral leishmaniasis. Infectious disease clinics of North America 2012
26(2):309-322. ; Roatt BM
Aguiar-Soares RD
Coura-Vital W
Ker HG
Moreira N
Vitoriano- Souza J
Giunchetti RC
Carneiro CM
Reis AB: Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease. Frontiers in immunology 2014
5:272. ; Lukes J
Mauricio IL
Schonian G
Soteriadou K
Dedet JP
Kuhls K
Tintaya KW
Jirku M
Chocholova E et al: Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proceedings of the National Academy of Sciences of the United States of America 2007
104(22):9375-9380. ; Banuls AL
Hide M
Prugnolle F: Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy
epidemiology and pathogenicity in humans. Advances in parasitology 2007
64:1-109. ; World Health O: Research priorities for Chagas disease
human African trypanosomiasis and leishmaniasis. World Health Organization technical report series 2012(975):v-xii
1-100. ; Boaventura VS
Cafe V
Costa J
Oliveira F
Bafica A
Rosato A
de Freitas LA
Brodskyn C
Barral-Netto M
Barral A: Concomitant early mucosal and cutaneous leishmaniasis in Brazil. The American journal of tropical medicine and hygiene 2006
75(2):267-269. ; Passi D
Sharma S
Dutta S
Gupta C: Localised leishmaniasis of oral mucosa: report of an unusual clinicopathological entity. Case reports in dentistry 2014
2014:753149. ; Costa JW
Jr.
Milner DA
Maguire JH: Mucocutaneous leishmaniasis in a US citizen. Oral surgery
oral medicine
oral pathology
oral radiology
and endodontics 2003
96(5):573-577. ; Torres EM
Sokolsky T
Tucker CM
Chan LY
Boselli M
Dunham MJ
Amon A: Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 2007
317(5840):916-924. ; Hernandez C
Alvarez C
Gonzalez C
Ayala MS
Leon CM
Ramirez JD: Identification of six New World Leishmania species through the implementation of a High-Resolution Melting (HRM) genotyping assay. Parasites & vectors 2014
7:501. ; Guerra JA
Prestes SR
Silveira H
Coelho LI
Gama P
Moura A
Amato V
Barbosa M
Ferreira LC: Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon. PLoS neglected tropical diseases 2011
5(3):e980. ; Medeiros AR
Silva WA
Roselino AM: DNA sequencing confirms the involvement of Leishmania (L.) amazonensis in American tegumentary leishmaniasis in the state of Sao Paulo
Brazil. Clinics 2008
63(4):451-456. ; Organización Panamericana de la Salud OMdlS: Manual de procedimientos para vigilancia y control de las leishmaniasis en las Américas. Recuperado de http://iris.paho.org/xmlui/bitstream/handle/123456789/50524/978927532063 1_spa.pdf?sequence=1&isAllowed=y. 2019. ; Azmi K
Nasereddin A
Schnur LF
Sawalha S
Hamarsheh O
Ereqat S
Amro A
Qaddomi SE
Abdeen Z: Epidemiological and clinical features of cutaneous leishmaniases in Jenin District
Palestine
including characterisation of the causative agents in clinical samples. Transactions of the Royal Society of Tropical Medicine and Hygiene 2012
106(9):554-562. ; Goto H
Lauletta Lindoso JA: Cutaneous and mucocutaneous leishmaniasis. Infectious disease clinics of North America 2012
26(2):293-307. ; Valderrama-Ardila C
Alexander N
Ferro C
Cadena H
Marin D
Holford TR
Munstermann LE
Ocampo CB: Environmental risk factors for the incidence of American cutaneous leishmaniasis in a sub-Andean zone of Colombia (Chaparral
Tolima). The American journal of tropical medicine and hygiene 2010
82(2):243-250. ; Ramirez JD
Hernandez C
Florez C
Gonzalez C: Taxonomy
diversity
temporal and geographical distribution of Cutaneous Leishmaniasis in Colombia: A retrospective study. Scientific reports 2016
6:28266. ; Camara Coelho LI
Paes M
Guerra JA
Coelho C
Lima B
Brito ME
Brandao Filho SP: Characterization of Leishmania spp. causing cutaneous leishmaniasis in Manaus
Amazonas
Brazil. Parasitology research 2011
108(3):671-677. ; Rodriguez-Barraquer I
Gongora R
Prager M
Pacheco R
Montero LM
Navas A
Miranda MC
Saravia NG: Etiologic agent of an epidemic of cutaneous leishmaniasis in Tolima
Colombia. The American journal of tropical medicine and hygiene 2008
78(2):276-282. ; Alvar J
Velez ID
Bern C
Herrero M
Desjeux P
Cano J
Jannin J
den Boer M
Team WHOLC: Leishmaniasis worldwide and global estimates of its incidence. PloS one 2012
7(5):e35671. ; Iantorno SA
Durrant C
Khan A
Sanders MJ
Beverley SM
Warren WC
Berriman M
Sacks DL
Cotton JA
Grigg ME: Gene Expression in Leishmania Is Regulated Predominantly by Gene Dosage. mBio 2017
8(5). ; Frieden TR
Centers for Disease C
Prevention: CDC Health Disparities and Inequalities Report - United States
2013. Foreword. MMWR supplements 2013
62(3):1-2. ; Almeida LV
Coqueiro-Dos-Santos A
Rodriguez-Luiz GF
McCulloch R
Bartholomeu DC
Reis-Cunha JL: Chromosomal copy number variation analysis by next generation sequencing confirms ploidy stability in Trypanosoma brucei subspecies. Microbial genomics 2018
4(10). ; Reis-Cunha JL
Rodrigues-Luiz GF
Valdivia HO
Baptista RP
Mendes TA
de Morais GL
Guedes R
Macedo AM
Gilman RH et al: Chromosomal copy number variation reveals differential levels of genomic plasticity in distinct Trypanosoma cruzi strains. BMC genomics 2015
16:499. ; Sivigila: Boletin epidemiológico. Sistema Nacional de Vigilancia en Salud Pública -SIVIGILA. 2018. ; Jariyapan N
Daroontum T
Jaiwong K
Chanmol W
Intakhan N
Sor-Suwan S
Siriyasatien P
Somboon P
Bates MD
Bates PA: Leishmania (Mundinia) orientalis n. sp. (Trypanosomatidae)
a parasite from Thailand responsible for localised cutaneous leishmaniasis. Parasites & vectors 2018
11(1):351. ; Akhoundi M
Cannet A
Votypka J
Marty P
Delaunay P
Sereno D: A Historical Overview of the Classification
Evolution
and Dispersion of Leishmania Parasites and Sandflies. PLoS neglected tropical diseases 2016
10(3):e0004349. ; Van der Auwera G
Dujardin JC: Species typing in dermal leishmaniasis. Clinical microbiology reviews 2015
28(2):265-294. ; Bates PA: Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. International journal for parasitology 2007
37(10):1097-1106. ; Gangneux JP
Menotti J
Lorenzo F
Sarfati C
Blanche H
Bui H
Pratlong F
Garin YJ
Derouin F: Prospective value of PCR amplification and sequencing for diagnosis and typing of old world Leishmania infections in an area of nonendemicity. Journal of clinical microbiology 2003
41(4):1419-1422. ; Arana M
Evans DA
Zolessi A
Cuentas AL
Arevalo J: Biochemical characterization of Leishmania (Viannia) braziliensis and Leishmania (Viannia) peruviana by isoenzyme electrophoresis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1990
84(4):526-529. ; Tsukayama P
Lucas C
Bacon DJ: Typing of four genetic loci discriminates among closely related species of New World Leishmania. International journal for parasitology 2009
39(3):355-362. ; Reithinger R
Dujardin JC: Molecular diagnosis of leishmaniasis: current status and future applications. Journal of clinical microbiology 2007
45(1):21- 25. ; Weigle KA
Labrada LA
Lozano C
Santrich C
Barker DC: PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia). Journal of clinical microbiology 2002
40(2):601-606. ; B SLFdS
Rezende AM
Melo Neto OP
Brito MEF
Brandao Filho SP: Identification of divergent Leishmania (Viannia) braziliensis ecotypes derived from a geographically restricted area through whole genome analysis. PLoS neglected tropical diseases 2019
13(6):e0007382. ; Ghouila A
Guerfali FZ
Atri C
Bali A
Attia H
Sghaier RM
Mkannez G
Dickens NJ
Laouini D: Comparative genomics of Tunisian Leishmania major isolates causing human cutaneous leishmaniasis with contrasting clinical severity. Infection
genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2017
50:110-120. ; Singh S
Sivakumar R: Challenges and new discoveries in the treatment of leishmaniasis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2004
10(6):307-315. ; do Monte-Neto RL
Coelho AC
Raymond F
Legare D
Corbeil J
Melo MN
Frezard F
Ouellette M: Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis. PLoS neglected tropical diseases 2011
5(5):e1167. ; Henao HH
Osorio Y
Saravia NG
Gomez A
Travi B: [Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application]. Biomedica : revista del Instituto Nacional de Salud 2004
24(4):393-402. ; Frezard F
Demicheli C
Ribeiro RR: Pentavalent antimonials: new perspectives for old drugs. Molecules 2009
14(7):2317-2336. ; Wang H
Xing X
Wang J
Pang B
Liu M
Larios-Valencia J
Liu T
Liu G
Xie S
Hao G et al: Hypermutation-induced in vivo oxidative stress resistance enhances Vibrio cholerae host adaptation. PLoS pathogens 2018
14(10):e1007413. ; Denamur E
Tenaillon O
Deschamps C
Skurnik D
Ronco E
Gaillard JL
Picard B
Branger C
Matic I: Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli. Genetics 2005
171(2):825-827. ; Frezard F
Ferreira CS
Costa MA: Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate. Antimicrobial agents and chemotherapy 2001
45(3):913-916. ; Mookerjee Basu J
Mookerjee A
Sen P
Bhaumik S
Banerjee S
Naskar K
Choudhuri SK
Saha B
Raha S et al: Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrobial agents and chemotherapy 2006
50(5):1788-1797. ; Wyllie S
Cunningham ML
Fairlamb AH: Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. The Journal of biological chemistry 2004
279(38):39925-39932. ; Moreira W
Leprohon P
Ouellette M: Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania. Cell death & disease 2011
2:e201. ; Sereno D
Holzmuller P
Mangot I
Cuny G
Ouaissi A
Lemesre JL: Antimonialmediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrobial agents and chemotherapy 2001
45(7):2064-2069. ; Moreira DS
Monte Neto RL
Andrade JM
Santi AM
Reis PG
Murta SM: Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony. International journal for parasitology Drugs and drug resistance 2013
3:143-153. ; Haldar AK
Roy S: Use of antimony in the treatment of leishmaniasis: current status and future directions. Molecular biology international 2011
2011:571242. ; Leon O
Roth M: Zinc fingers: DNA binding and protein-protein interactions. Biological research 2000
33(1):21-30. ; Webb JR
McMaster WR: Molecular cloning and expression of a Leishmania major gene encoding a single-stranded DNA-binding protein containing nine "CCHC" zinc finger motifs. The Journal of biological chemistry 1993
268(19):13994-14002. ; Frezard F
Monte-Neto R
Reis PG: Antimony transport mechanisms in resistant leishmania parasites. Biophysical reviews 2014
6(1):119-132. ; Ouellette M
Drummelsmith J
Papadopoulou B: Leishmaniasis: drugs in the clinic
resistance and new developments. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2004
7(4- 5):257-266. ; Sundar S
Singh A: Recent developments and future prospects in the treatment of visceral leishmaniasis. Therapeutic advances in infectious disease 2016
3(3-4):98-109. ; Chappuis F
Sundar S
Hailu A
Ghalib H
Rijal S
Peeling RW
Alvar J
Boelaert M: Visceral leishmaniasis: what are the needs for diagnosis
treatment and control? Nature reviews Microbiology 2007
5(11):873-882. ; Croft SL
Olliaro P: Leishmaniasis chemotherapy--challenges and opportunities. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2011
17(10):1478-1483. ; Jha SN
Singh NK
Jha TK: Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial. The Journal of the Association of Physicians of India 1991
39(4):314-316. ; Amato VS
Tuon FF
Bacha HA
Neto VA
Nicodemo AC: Mucosal leishmaniasis . Current scenario and prospects for treatment. Acta tropica 2008
105(1):1-9. ; Singh N
Kumar M
Singh RK: Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pacific journal of tropical medicine 2012
5(6):485-497. ; WHO (2010) Control of the Leishmaniasis RoamotWECotCoL. ; Bray PG
Barrett MP
Ward SA
de Koning HP: Pentamidine uptake and resistance in pathogenic protozoa: past
present and future. Trends in parasitology 2003
19(5):232-239. ; Fernandez OL
Diaz-Toro Y
Ovalle C
Valderrama L
Muvdi S
Rodriguez I
Gomez MA
Saravia NG: Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia. PLoS neglected tropical diseases 2014
8(5):e2871. ; Dorlo TP
Balasegaram M
Beijnen JH
de Vries PJ: Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. The Journal of antimicrobial chemotherapy 2012
67(11):2576-2597. ; Murray HW: Leishmaniasis in the United States: treatment in 2012. The American journal of tropical medicine and hygiene 2012
86(3):434-440. ; Tahir M
Bashir U
Hafeez J
Ghafoor R: Safety and efficacy of miltefosine in cutaneous leishmaniasis: An open label
non-comparative study from Balochistan. Pakistan journal of medical sciences 2019
35(2):495-499. ; Rubiano LC
Muvdi Arenas S
Rodriguez-Barraquer I
Garcerant D
Osorio L
Rojas MX
Perez M et al: Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children. The Journal of infectious diseases 2012
205(4):684-692. ; Obonaga R
Fernandez OL
Rubiano LC
Castro Mdel M
Barrera MC
Gore Saravia N: Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species. Antimicrobial agents and chemotherapy 2014
58(1):144-152. ; Soto J
Arana BA
Toledo J
Rizzo N
Vega JC
Diaz A
Luz M
Gutierrez P
Arboleda M
Berman JD et al: Miltefosine for new world cutaneous leishmaniasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004
38(9):1266-1272. ; Sundar S: Drug resistance in Indian visceral leishmaniasis. Tropical medicine & international health : TM & IH 2001
6(11):849-854. ; Hadighi R
Mohebali M
Boucher P
Hajjaran H
Khamesipour A
Ouellette M: Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS medicine 2006
3(5):e162. ; Bermudez H
Rojas E
Garcia L
Boelaert M
Chappuis F: Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate
for the treatment of tegumentary leishmaniasis in Isiboro Secure Park
Bolivia. Annals of tropical medicine and parasitology 2006
100(7):591-600. ; Romero GA
Guerra MV
Paes MG
Macedo VO: Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. The American journal of tropical medicine and hygiene 2001
65(5):456-465. ; Teixeira AC
Guerra Jde O
Prata A
Silva-Vergara ML: Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus
AM
Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo 2008
50(3):157-160. ; Tuon FF
Amato VS: Leishmania: origin
evolution and future since the Precambrian. FEMS immunology and medical microbiology 2008
54(2):158-166. ; Llanos-Cuentas A
Tulliano G
Araujo-Castillo R
Miranda-Verastegui C
Santamaria-Castrellon G
Ramirez L
Lazo M
De Doncker S
Robays J et al: Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008
46(2):223-231. ; Valencia C
Chappuis F
Zimic M: Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions. PLoS neglected tropical diseases 2012
6(6):e1656. ; Arevalo J
Adaui V
Zimic M
Loayza-Muro R
Maurer A et al: Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. The Journal of infectious diseases 2007
195(12):1846-1851. ; Palacios R
Osorio LE
Grajalew LF
Ochoa MT: Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species. The American journal of tropical medicine and hygiene 2001
64(3-4):187-193. ; Rojas R
Valderrama M
Varona MX
Ouellette M
Saravia NG: Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. The Journal of infectious diseases 2006
193(10):1375- 1383. ; Perez-Franco JE
Cruz-Barrera ML
Robayo ML
Lopez MC
Daza CD
Bedoya A
Marino ML
Saavedra CH
Echeverry MC: Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate. PLoS neglected tropical diseases 2016
10(5):e0004739. ; Laffitte MN
Papadopoulou B
Ouellette M: Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance. F1000Research 2016
5:2350. ; Brotherton MC
Bourassa S
Poirier GG
Droit A
Ouellette M: Proteomic and genomic analyses of antimony resistant Leishmania infantum mutant. PloS one 2013
8(11):e81899. ; Matrangolo FS
Liarte DB
Andrade LC
de Melo MF
Ferreira RF
Santiago AS
Pirovani CP
Silva-Pereira RA
Murta SM: Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines. Molecular and biochemical parasitology 2013
190(2):63-75. ; Kaur G
Rajput B: Comparative analysis of the omics technologies used to study antimonial
amphotericin B
and pentamidine resistance in leishmania. Journal of parasitology research 2014
2014:726328. ; Downing T
Imamura H
Decuypere S
Clark TG
Coombs GH
Hilley JD
de Doncker S
Maes I
Mottram JC et al: Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome research 2011
21(12):2143-2156. ; Rastrojo A
Garcia-Hernandez R
Vargas P
Camacho E
Corvo L
Castanys S
Aguado B
Gamarro F et al: Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs. International journal for parasitology Drugs and drug resistance 2018
8(2):246-264. ; Valdivia HO
Reis-Cunha JL
Baldeviano GC
Gerbasi RV
Dobson DE
Bastien P
Lescano AG et al: Comparative genomic analysis of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis. BMC genomics 2015
16:715. ; Urrea DA
Duitama J
Alzate JF
Gil J
Munoz N
Villa JA
Ramirez-Pineda JR
Triana-Chavez O: Genomic Analysis of Colombian Leishmania panamensis strains with different level of virulence. Scientific reports 2018
8(1):17336. ; Kuhls K
Presber W
Schonian G: Analysis of ribosomal DNA internal transcribed spacer sequences of the Leishmania donovani complex. Microbes and infection 2005
7(11-12):1224-1234. ; Herrera G
Teheran AA
Ramirez JD: Evaluation of a Multilocus Sequence Typing (MLST) scheme for Leishmania (Viannia) braziliensis and Leishmania (Viannia) panamensis in Colombia. Parasites & vectors 2017
10(1):236. ; Bhattarai NR
Van der Auwera G: Development and evaluation of different PCR-based typing methods for discrimination of Leishmania donovani isolates from Nepal. Parasitology 2010
137(6):947-957. ; Odiwuor S
Vuylsteke M
Mbuchi M
Van der Auwera G: Leishmania AFLP: paving the way towards improved molecular assays and markers of diversity. Infection
genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2011
11(5):960-967. ; Peacock CS
Seeger K
Harris D
Murphy L
Ruiz JC
Quail MA
Peters N
Adlem E
Tivey A
Aslett M et al: Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nature genetics 2007
39(7):839- 847. ; Zackay A
Sanders M
Warburg A
Jaffe CL: Genome wide comparison of Ethiopian Leishmania donovani strains reveals differences potentially related to parasite survival. PLoS genetics 2018
14(1):e1007133. ; Rogers MB
Wilkes J
Bates PA
Depledge DP
Her Y
Herzyk P
Imamura H et al: Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome research 2011
21(12):2129-2142. ; Imamura H
Downing T
Van den Broeck F
Mannaert A
Vanaerschot M
Berg M
De Muylder G et al: Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent. eLife 2016
5. ; Leprohon P
Fernandez-Prada C
Gazanion E
Ouellette M: Drug resistance analysis by next generation sequencing in Leishmania. International journal for parasitology Drugs and drug resistance 2015
5(1):26- 35. ; Mukherjee A
Boisvert S
Monte-Neto RL
Ouellette M: Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania. Molecular microbiology 2013
88(1):189-202. ; Monte-Neto R
Laffitte MC
Reis P
Ouellette M: Intrachromosomal amplification
locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis. PLoS neglected tropical diseases 2015
9(2):e0003476. ; Fernandez-Prada C
Sharma M
Plourde M
Bresson E
Roy G
Ouellette M: High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms. International journal for parasitology Drugs and drug resistance 2018
8(2):165- 173. ; Ashutosh
Goyal N: Molecular mechanisms of antimony resistance in Leishmania. Journal of medical microbiology 2007
56(Pt 2):143-153. ; Frézard F
Reis PG: Antimony transport mechanisms in resistant leishmania parasites. Biophysical Reviews 2014
6(1):119-132. ; Dumetz F
Cuypers B
Zander D
D'Haenens E
Domagalska MA
Clos J
De Muylder G: Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent. mSphere 2018
3(2). ; Inbar E
Hughitt VK
Dillon LA
Ghosh K
El-Sayed NM
Sacks DL: The Transcriptome of Leishmania major Developmental Stages in Their Natural Sand Fly Vector. mBio 2017
8(2). ; Valdivia HO
Almeida LV
Roatt BM
Pereira AA
Gontijo C
Fujiwara RT
Reis AB
Cotton JA et al: Comparative genomics of canine-isolated Leishmania (Leishmania) amazonensis from an endemic focus of visceral leishmaniasis in Governador Valadares
southeastern Brazil. Scientific reports 2017
7:40804. ; Real F
Vidal RO
Carazzolle MF
Mondego JM
Costa GG
Herai RH
Wurtele M
de Carvalho LM
Carmona e Ferreira R
Pokaż więcej
Temat :
Leishmania
Resistencia
ADN-seq
ARN-seq
Glucantime
Somia
VNC
SNPs
Ciencias médicas
Medicina
Enfermedades
Leishmaniasis
DNA-seq
RNA seq
CNV
Resistance
Źródło :
instname:Universidad del Rosario ; reponame:Repositorio Institucional EdocUR ; Herwaldt BL: Leishmaniasis. Lancet 1999, 354(9185):1191-1199. ; Fraga J, Veland N, Montalvo AM, Praet N, Boggild AK, Valencia BM, Arevalo J, Llanos-Cuentas A, Dujardin JC, Van der Auwera G: Accurate and rapid species typing from cutaneous and mucocutaneous leishmaniasis lesions of the New World. Diagnostic microbiology and infectious disease 2012, 74(2):142- 150. ; Marquis N, Gourbal B, Rosen BP, Mukhopadhyay R, Ouellette M: Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Molecular microbiology 2005, 57(6):1690-1699. ; Desjeux P: Leishmaniasis: current situation and new perspectives. Comparative immunology, microbiology and infectious ....
Opis pliku :
application/pdf
Relacje :
https://repository.urosario.edu.co/handle/10336/20397
Dostępność :
https://repository.urosario.edu.co/handle/10336/20397
Dysertacja/Praca dyplomowa
Tytuł :
Active community surveillance of the impact of different tuberculosis control measures, Tiruvallur, South India, 1968-2001
Autorzy :
Subramani, R
Santha, T
Frieden, TR
Radhakrishna, S
Gopi, PG
Selvakumar, N
Sadacharam, K
Narayanan, PR
Pokaż więcej
Temat :
Infectious Diseases
Opis pliku :
text/html
Relacje :
http://ije.oxfordjournals.org/cgi/content/short/36/2/387; http://dx.doi.org/10.1093/ije/dyl216
Dostępność :
https://doi.org/10.1093/ije/dyl216
http://ije.oxfordjournals.org/cgi/content/short/36/2/387
Czasopismo naukowe
Tytuł :
Global health security: the wider lessons from the west African Ebola virus disease epidemic.
Autorzy :
Heymann, DL
Chen, L
Takemi, K
Fidler, DP
Tappero, JW
Thomas, MJ
Kenyon, TA
Frieden, TR
Yach, D
Nishtar, S
Kalache, A
Olliaro, PL
Horby, P
Torreele, E
Gostin, LO
Ndomondo-Sigonda, M
Carpenter, D
Rushton, S
Lillywhite, L
Devkota, B
Koser, K
Yates, R
Dhillon, RS
Rannan-Eliya, RP
Pokaż więcej
Relacje :
Heymann, DL ; Chen, L; Takemi, K; Fidler, DP; Tappero, JW; Thomas, MJ; Kenyon, TA; Frieden, TR; Yach, D; Nishtar, S; +14 more. Kalache, A; Olliaro, PL; Horby, P; Torreele, E; Gostin, LO; Ndomondo-Sigonda, M; Carpenter, D; Rushton, S; Lillywhite, L; Devkota, B; Koser, K; Yates, R; Dhillon, RS; Rannan-Eliya, RP; (2015) Global health security: the wider lessons from the west African Ebola virus disease epidemic. Lancet, 385 (9980). pp. 1884-901. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(15)60858-3
Dostępność :
https://doi.org/10.1016/S0140-6736(15)60858-3
http://researchonline.lshtm.ac.uk/2172824/
Czasopismo naukowe
Tytuł :
Global Tuberculosis Perspectives, Prospects, and Priorities
Autorzy :
Frieden, TR
Brudney, KF
Harries, AD
Pokaż więcej
Opis pliku :
text
Relacje :
https://researchonline.lshtm.ac.uk/2017858/1/Global%20Tuberculosis_GOLD%20VoR.pdf; Frieden, TR; Brudney, KF; Harries, AD ; (2014) Global Tuberculosis Perspectives, Prospects, and Priorities. JAMA, 312 (14). pp. 1393-1394. ISSN 0098-7484 DOI: https://doi.org/10.1001/jama.2014.11450
Dostępność :
https://doi.org/10.1001/jama.2014.11450
http://researchonline.lshtm.ac.uk/2017858/
https://researchonline.lshtm.ac.uk/2017858/1/Global%20Tuberculosis_GOLD%20VoR.pdf
Czasopismo naukowe
Tytuł :
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.
Autorzy :
Frieden TR ()
Sherman LF ()
Maw KL ()
Fujiwara PI ()
Crawford JT ()
Nivin B ()
Sharp V ()
Hewlett D Jr. ()
Brudney K ()
Alland D ()
Kreiswirth BN ()
Frieden, T R ()
Sherman, L F ()
Maw, K L ()
Fujiwara, P I ()
Crawford, J T ()
Nivin, B ()
Sharp, V ()
Hewlett, D Jr ()
Brudney, K ()
Pokaż więcej
Źródło :
JAMA: Journal of the American Medical Association. 10/16/96, Vol. 276 Issue 15, p1229-1235. 7p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies